HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giannino Del Sal Selected Research

trimethylguanosine synthase

1/2022TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giannino Del Sal Research Topics

Disease

51Neoplasms (Cancer)
01/2022 - 05/2002
10Breast Neoplasms (Breast Cancer)
12/2020 - 06/2013
5Carcinogenesis
01/2020 - 05/2002
5Neoplasm Metastasis (Metastasis)
01/2019 - 01/2015
3Infections
12/2017 - 03/2010
3Triple Negative Breast Neoplasms
01/2017 - 01/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
12/2017 - 05/2015
2Inflammation (Inflammations)
01/2017 - 04/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2014 - 11/2011
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2013 - 11/2011
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Premature Aging
01/2021
1Fibrosis (Cirrhosis)
01/2019
1Hepatitis B
12/2017
1Hyperinsulinism (Hyperinsulinemia)
01/2017
1Burkitt Lymphoma (Burkitt's Lymphoma)
04/2016
1Ischemia
10/2015
1Diabetic Angiopathies (Diabetic Angiopathy)
04/2015
1Wilms Tumor (Wilm's Tumor)
12/2013
1Genomic Instability
05/2013
1Ovarian Neoplasms (Ovarian Cancer)
05/2013
1Huntington Disease (Huntington's Disease)
11/2011

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
7Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
01/2021 - 07/2004
7Pharmaceutical PreparationsIBA
12/2020 - 01/2011
5MicroRNAs (MicroRNA)IBA
01/2021 - 06/2013
5Transcription Factors (Transcription Factor)IBA
08/2014 - 03/2003
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2006
3Phosphotransferases (Kinase)IBA
01/2022 - 11/2011
3Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 01/2015
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2019
2eprenetapoptIBA
04/2018 - 01/2016
2Genetic Markers (Genetic Marker)IBA
01/2018 - 11/2015
2NF-kappa B (NF-kB)IBA
01/2018 - 04/2015
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 - 01/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 06/2010
2AntigensIBA
01/2017 - 12/2013
2EnzymesIBA
01/2017 - 03/2010
2Proteasome InhibitorsIBA
01/2017 - 01/2016
2Mutant Proteins (Protein, Mutant)IBA
01/2017 - 01/2015
2Biological ProductsIBA
11/2014 - 05/2002
2IntegrasesIBA
01/2014 - 03/2010
1trimethylguanosine synthaseIBA
01/2022
1Threonine (L-Threonine)FDA Link
01/2022
1Serine (L-Serine)FDA Link
01/2022
1UbiquitinIBA
01/2022
1Ligases (Synthetase)IBA
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022
1N(2),N(2),7-trimethylguanosineIBA
01/2022
1AndrogensIBA
01/2022
1telomerase RNA (bTR)IBA
01/2022
1phytobacteriomycin (PBM)IBA
01/2022
1TESIBA
01/2021
1ChromatinIBA
01/2021
1DNA Transposable Elements (Element, IS)IBA
01/2021
1Liposomes (Liposome)IBA
01/2021
1HeterochromatinIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
12/2020
1human ERBB2 proteinIBA
12/2020
1Haloperidol (Haldol)FDA LinkGeneric
01/2019
1MethyltransferasesIBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Auranofin (Ridaura)FDA Link
04/2018
1Heme Oxygenase-1IBA
04/2018
1AntioxidantsIBA
04/2018
1ThioredoxinsIBA
04/2018
1Aflatoxin B1 (Aflatoxin B)IBA
12/2017
1quinone (benzoquinone)IBA
01/2017
1EpitopesIBA
01/2017
1NIMA-Interacting Peptidylprolyl IsomeraseIBA
01/2017
1Insulin (Novolin)FDA Link
01/2017
1Peptides (Polypeptides)IBA
01/2017
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2017
1HLA-A*02:01 antigenIBA
01/2017
1Protein SIBA
01/2017
1Codon (Codons)IBA
04/2016
1Cyclin BIBA
02/2016
1Cyclin AIBA
02/2016
1carfilzomibIBA
01/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2015
1Dasatinib (BMS 354825)FDA Link
11/2015
1IsomerasesIBA
10/2015
1Bortezomib (Velcade)FDA Link
05/2015
1CytokinesIBA
12/2014
1ChemokinesIBA
12/2014
1Mevalonic Acid (Mevalonate)IBA
04/2014
1CateninsIBA
12/2013
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
05/2013
1StathminIBA
05/2013
1Huntingtin ProteinIBA
11/2011
1Protein Kinases (Protein Kinase)IBA
11/2011

Therapy/Procedure

12Therapeutics
01/2019 - 08/2008
2Immunotherapy
01/2021 - 01/2017
2Drug Therapy (Chemotherapy)
01/2019 - 11/2014
1Investigational Therapies (Experimental Therapy)
01/2021